Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Illumina Inc.
Index- P/E98.06 EPS (ttm)1.91 Insider Own0.60% Shs Outstand142.00M Perf Week0.25%
Market Cap26.60B Forward P/E59.18 EPS next Y3.17 Insider Trans3.52% Shs Float140.26M Perf Month-1.35%
Income280.70M PEG3.97 EPS next Q0.78 Inst Own95.50% Short Float1.58% Perf Quarter8.73%
Sales1.74B P/S15.32 EPS this Y-20.40% Inst Trans-0.91% Short Ratio1.83 Perf Half Y7.01%
Book/sh9.03 P/B20.74 EPS next Y19.70% ROA9.10% Target Price204.87 Perf Year79.02%
Cash/sh8.95 P/C20.92 EPS next 5Y24.70% ROE20.60% 52W Range102.16 - 197.37 Perf YTD69.36%
Dividend- P/FCF71.13 EPS past 5Y24.60% ROI3.90% 52W High-5.11% Beta0.76
Dividend %- Quick Ratio2.00 Sales past 5Y19.90% Gross Margin67.50% 52W Low83.33% ATR5.81
Employees3000 Current Ratio2.20 Sales Q/Q34.70% Oper. Margin23.30% RSI (14)52.82 Volatility3.62% 2.89%
OptionableYes Debt/Eq1.01 EPS Q/Q186.40% Profit Margin16.20% Rel Volume1.17 Prev Close181.21
ShortableYes LT Debt/Eq0.77 EarningsOct 20 AMC Payout0.00% Avg Volume1.21M Price187.29
Recom1.90 SMA200.10% SMA502.83% SMA20012.13% Volume1,404,000 Change3.36%
Oct-27-14Reiterated Stifel Buy $200 → $215
Oct-21-14Reiterated ISI Group Neutral $175 → $180.50
Aug-12-14Initiated Stifel Buy $200
Aug-01-14Initiated Tigress Financial Buy
Jul-24-14Reiterated Mizuho Buy $200 → $220
Jul-17-14Reiterated Maxim Group Buy $205 → $220
Apr-23-14Upgrade Maxim Group Hold → Buy $205
Apr-23-14Reiterated Mizuho Buy $175 → $200
Apr-23-14Reiterated ISI Group Neutral $152.50 → $162.50
Feb-19-14Reiterated UBS Buy $152 → $202
Jan-29-14Reiterated Mizuho Buy $150 → $175
Jan-29-14Reiterated ISI Group Neutral $134.50 → $147
Jan-17-14Reiterated Mizuho Buy $135 → $150
Jan-14-14Reiterated Mizuho Buy $125 → $135
Dec-19-13Reiterated Mizuho Buy $100 → $125
Oct-22-13Reiterated Mizuho Buy $86 → $100
Oct-22-13Reiterated Barclays Overweight $85 → $90
Jul-24-13Reiterated Mizuho Buy $83 → $86
Jul-24-13Reiterated ISI Group Neutral $75 → $78.50
Jul-23-13Reiterated UBS Buy $67 → $90
Dec-18-14 11:51AM  Stocks Up Big; Restoration, Accenture Hit New Highs at Investor's Business Daily
Dec-17-14 01:24PM  Stocks Hold Near Highs Ahead of Fed Announcement at Investor's Business Daily
Dec-15-14 01:29PM  Stocks Stage Comeback; Leaders Still Under Pressure at Investor's Business Daily
Dec-10-14 05:57AM  Kite Pharma (KITE) Shows Strength: Stock Moves Up 16.4% Zacks
05:53AM  Celladon Corp. (CLDN) Jumps: Stock Adds 14.7% in Session Zacks
Dec-09-14 05:50AM  bluebird bio (BLUE) in Focus: Stock Surges 9.4% Zacks
Dec-08-14 06:30AM  uniQure N.V. (QURE) Jumps: Stock Adds 6.3% in Session Zacks
Dec-06-14 04:06AM  My 2014 Healthcare Top 10 List at Forbes
Dec-05-14 04:16PM  ILLUMINA INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Dec-04-14 05:45PM  Amgen's Blincyto Gets FDA Nod, Carries Boxed Warning Zacks
Dec-03-14 05:00PM  Tesla hits oil slick CNBC
12:14PM  Sequenom (SQNM) Stock Spikes Following NIPT Patent Settlement With Illumina at TheStreet
10:58AM  Sequenom climbs as Illumina patent dispute ends AP
10:42AM  Mid-Morning Market Update: Markets Mixed; Abercrombie & Fitch Lowers Earnings Guidance Benzinga
06:28AM  ImmunoCellular Therapeutics (IMUC) Soars: Stock Rises 40.9% Zacks
06:00AM  Illumina and Sequenom Pool Noninvasive Prenatal Testing Intellectual Property and End Outstanding Patent Disputes Business Wire
02:50AM  UK wage conundrum in spotlight ahead of Autumn Statement CNBC
Dec-02-14 05:14PM  Alexandria Real Estate REIT Inks Rx For Pharma Boom at Investor's Business Daily
07:48AM  Intra-Cellular Therapies (ITCI) Jumps: Stock Rises 6.8% Zacks
Nov-28-14 05:35AM  Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% Zacks
Nov-21-14 04:20PM  Is Illumina (ILMN) Worth Adding to Your Portfolio? Zacks
10:24AM  Covenant Transport (CVTI) & Inteliquent (IQNT): Top Stocks to Add to Your Momentum Portfolio Zacks
08:02AM  Meet 5 Top Stocks With Rising Earnings Estimates at Investor's Business Daily
Nov-19-14 05:01PM  The Forbes Healthcare Summit 2014: The Agenda at Forbes
04:15PM  Fluidigm's (FLDM) New Workflow to Allow High Throughput Zacks
02:20PM  Illumina, bioMerieux to Co-develop NGS Epidemiology Solution Zacks
11:21AM  Illumina teams with U.S. government, researchers to sequence Ebola Reuters
06:00AM  USAID, Broad Institute and Illumina Form a Public-Private Partnership Combating the Ebola Epidemic in West Africa Business Wire
Nov-18-14 01:00AM  bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections Business Wire
Nov-14-14 09:35PM  Big Ideas, Big Picture at
06:47PM  Medical Stocks Tumble But Most Of IBD 50 Trading Well at Investor's Business Daily
04:27PM  ILLUMINA INC Files SEC form 8-K, Other Events EDGAR Online
04:21PM  Stock Market Treads Water; Earnings Drive BitAuto at Investor's Business Daily
01:32PM  Stocks Mixed; Amazon Jumps On Book Deal at Investor's Business Daily
Nov-13-14 01:20PM  Qiagen Partners with Novartis for Companion Diagnostics Zacks
Nov-11-14 09:10AM  New Cancer Detection Technique Has Enormous Potential for Life Science Stocks at 24/7 Wall St.
05:37AM  Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% Zacks
Nov-10-14 09:37PM  Why this expert is buying into gold CNBC
07:34PM  Big Cap 20 Stuffed With Medical Names at Investor's Business Daily
Nov-06-14 06:41PM  Top Large-Cap Growth Mutual Funds Defy Gravity at Investor's Business Daily
06:41PM  Accumulation/Distribution Rating Tells You What Pros Are Doing Investor's Business Daily
06:00AM  'Mad Money' Lightning Round: Pull the Trigger on Baxter at TheStreet
Nov-05-14 04:08PM  ILLUMINA INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year EDGAR Online
01:04PM  ILLUMINA INC Financials EDGAR Online Financials
Nov-04-14 03:35PM  Taking Stock: Wood on Investing in Illumina, Tesla, Twitter at Bloomberg
05:32AM  Geron Corporation (GERN) Looks Strong: Stock Up 25.6% Zacks
Nov-03-14 10:42AM  Rothberg Returns With Star Trek-Like Medical Device To Create Images And Cut With Sound Waves at Forbes
02:23AM  Prosensa Holding N.V. (RNA) Jumps: Stock Moves Up 9.9% Zacks
Oct-31-14 08:08PM  10-Q for Illumina, Inc. Company Spotlight
06:47PM  IBD 50 Caps Impressive 2-Week Rally at Investor's Business Daily
08:13AM  Incyte (INCY) Looks Good: Stock Moves 10.9% Higher Zacks
03:11AM  Bristol-Myers Squibb (BMY) Jumps: Stock Moves Up 8.9% Zacks
03:07AM  Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% Zacks
Oct-30-14 07:02AM  HTG Announces Completion of IVD Development and Supply Agreement With Illumina Marketwired
03:22AM  Cara Therapeutics (CARA) Worth Watching: Stock Rises 6.4% Zacks
Oct-29-14 04:06PM  ILLUMINA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
03:00PM  Illumina's Break Could Be Investor's Gain Benzinga
08:02AM  Chipotle And Apple Suppliers Rise Among 5 Young Guns at Investor's Business Daily
06:44AM  Netflix and two other stocks disrupting their way to success Yahoo Finance
Oct-28-14 06:44AM  Can Illumina (ILMN) Stock Continue to Grow Earnings? Zacks
06:27AM  Novavax (NVAX) in Focus: Stock Rises 13% Zacks
Oct-27-14 07:00PM  Four Biotechs Lead Health Care Stocks In Big Cap 20 at Investor's Business Daily
06:15PM  Allergan CEO: Huge momentum in sales growth CNBC
06:44AM  Surging Earnings Estimates Signal Good News for Illumina Inc. (ILMN) Zacks
02:15AM  Verastem (VSTM) Shows Strength: Stock Adds 7% in Session Zacks
02:12AM  BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 8% Zacks
Oct-24-14 01:00PM  BioMarin Q3 Loss Narrower than Expected, View Raised Zacks
06:47AM  Fate Therapeutics (FATE) Crumbles: Stock Tumbles by 10.6% Zacks
Oct-23-14 10:43PM  Facebook Among 10 IBD 50 Stocks With Rising Estimates at Investor's Business Daily
06:24PM  Five Leading Stocks Stage Breakouts As Market Rallies at Investor's Business Daily
Oct-22-14 04:24PM  Major Indexes End Win Streak; Super Micro Surges at Investor's Business Daily
12:51PM  Covenant Transport (CVTI) & Illumina (ILMN): This Week's Top Momentum Stocks Zacks
06:43AM  Illumina (ILMN) Looks Strong: Stock Gains 9.2% Zacks
Oct-21-14 05:42PM  The Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs +9.17%
04:24PM  Stocks Extend Comeback; S&P 500 Retakes 200-Day Line at Investor's Business Daily
03:08PM  Why Everyone Likes Illumina Again at 24/7 Wall St.
03:01PM  Stocks Further Extend Gains; Airlines, Medicals Soar at Investor's Business Daily
01:08PM  Harley-Davidson Climbs On Upbeat Earnings; Coca-Cola Shares Dip Benzinga
12:55PM  Harley-Davidson shares gain as earnings beat expectations at Financial Times
12:55PM  Illumina Stock Soars As Analysts Laud Earnings at Investor's Business Daily
10:38AM  Stocks Post Solid Early Advance; Apple Lifts Nasdaq, S&P 500 at Investor's Business Daily
09:50AM  Illumina (ILMN) Showing Signs Of Being A Momo Momentum Stock at TheStreet
09:35AM  Why Illumina (ILMN) Stock Is Soaring Today at TheStreet
09:14AM  Morning Movers: Coca-Cola Drops on Big Miss; Chipotle Slumps on Guidance at
08:59AM  Stock Futures Point Higher; Earnings Boost Illumina, Apple at Investor's Business Daily
08:40AM  Illumina (ILMN) Tops Q3 Earnings, Revenues; Ups Guidance Zacks
07:04AM  Illumina (ILMN) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
05:20AM  Why this pro likes 'high octane' tech stocks CNBC
02:38AM  Vital Therapies (VTL) in Focus: Stock Adds 7.9% in Session Zacks
Oct-20-14 07:08PM  Gene Sequencer Illumina's Q3 Well In Order Investor's Business Daily
05:17PM  Illumina Spikes 10% On Q3 Earnings Beat Benzinga
05:07PM  Why Illumina (ILMN) Stock Is Gaining in After-Hours Trading Today at TheStreet
05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:15PM  Illumina beats Street 3Q forecasts AP
04:07PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  Illumina Reports Record Financial Results for Third Quarter of Fiscal Year 2014 Business Wire
07:07AM  Q3 2014 Illumina Inc Earnings Release - After Market Close CCBN
Oct-18-14 08:02AM  Celgene, Alexion Among 4 IBD 50 Medicals To Report at Investor's Business Daily
Oct-17-14 06:48PM  IBD 50: Five Stocks Forming Intriguing Chart Patterns at Investor's Business Daily
06:30AM  Illumina Launches New Reagent Kits for HiSeq X Ten and HiSeq 2500 Systems Business Wire
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has strategic partnerships with AstraZeneca PLC; Janssen Biotech, Inc.; and Sanofi to focus on the transition from single-analyte companion diagnostics to panel-based assays that select for companion therapeutics. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALT DAVID RDirectorDec 16Sale178.355,000891,768869,630Dec 17 09:41 PM
Stapley MarcSr VP & CFODec 15Option Exercise36.301,42251,61925,706Dec 17 01:54 PM
Stapley MarcSr VP & CFODec 15Sale181.091,422257,50424,284Dec 17 01:54 PM
FLATLEY JAY TChief Executive OfficerDec 11Option Exercise20.0425,000501,000415,478Dec 12 07:00 PM
FLATLEY JAY TChief Executive OfficerDec 11Sale185.7925,0004,644,805390,478Dec 12 07:00 PM
WALT DAVID RDirectorDec 09Sale186.792,000373,57680,960Dec 11 08:02 PM
WALT DAVID RDirectorDec 09Sale186.735,000933,645874,630Dec 11 08:02 PM
BRADBURY DANIELDirectorDec 08Option Exercise42.821,60068,51214,066Dec 09 08:14 PM
BRADBURY DANIELDirectorDec 08Sale190.141,600304,21812,466Dec 09 08:14 PM
EASTHAM KARINDirectorDec 04Option Exercise42.8210,000428,20019,726Dec 05 07:54 PM
EASTHAM KARINDirectorDec 04Sale191.8710,0001,918,7259,726Dec 05 07:54 PM
Bouchard MichelChief Accounting OfficerDec 01Option Exercise69.3463143,75424,821Dec 02 05:36 PM
Ronaghi MostafaSr VP & CTODec 01Option Exercise44.3810,000443,80038,604Dec 02 05:35 PM
Bouchard MichelChief Accounting OfficerDec 01Sale187.43631118,26724,190Dec 02 05:36 PM
Ronaghi MostafaSr VP & CTODec 01Sale188.4610,0001,884,64528,604Dec 02 05:35 PM
FLATLEY JAY TChief Executive OfficerNov 28Option Exercise20.0425,000501,000406,262Dec 02 05:35 PM
Dadswell CharlesSr VP & General CounselNov 28Sale192.7615028,91442,089Dec 02 05:35 PM
FLATLEY JAY TChief Executive OfficerNov 28Sale189.7925,0004,744,761381,262Dec 02 05:35 PM
Bianchi Paul LSr VP, Human ResourcesNov 26Sale189.201,626307,63957,770Nov 26 07:19 PM
WHITFIELD ROY ADirectorNov 17Option Exercise19.614,00078,44015,738Nov 17 07:06 PM
WHITFIELD ROY ADirectorNov 17Sale178.264,000713,04011,738Nov 17 07:06 PM
Stapley MarcSr VP & CFONov 14Option Exercise36.301,42251,61923,533Nov 17 06:52 PM
Stapley MarcSr VP & CFONov 14Sale181.131,422257,56522,111Nov 17 06:52 PM
FLATLEY JAY TChief Executive OfficerNov 13Option Exercise20.0425,000501,000406,262Nov 14 06:06 PM
FLATLEY JAY TChief Executive OfficerNov 13Sale189.3225,0004,732,994381,262Nov 14 06:06 PM
Bouchard MichelChief Accounting OfficerNov 03Option Exercise69.3463143,75424,821Nov 05 06:10 PM
Ronaghi MostafaSr VP & CTONov 03Option Exercise44.3810,000443,80038,604Nov 05 06:09 PM
Bouchard MichelChief Accounting OfficerNov 03Sale195.68631123,47424,190Nov 05 06:10 PM
Ronaghi MostafaSr VP & CTONov 03Sale195.6610,0001,956,61328,604Nov 05 06:09 PM
BRADBURY DANIELDirectorOct 30Option Exercise42.822,10089,92214,566Oct 31 02:25 PM
BRADBURY DANIELDirectorOct 30Sale191.832,100402,83512,466Oct 31 02:25 PM
Dadswell CharlesSr VP & General CounselOct 27Sale189.8414727,90642,239Oct 28 12:17 PM
FLATLEY JAY TChief Executive OfficerOct 23Option Exercise20.0425,000501,000406,262Oct 24 12:07 PM
FLATLEY JAY TChief Executive OfficerOct 23Sale189.5425,0004,738,446381,262Oct 24 12:07 PM
Naclerio NicholasSr VP, Corp DevelopmentOct 15Option Exercise43.372,00086,74025,146Oct 16 08:09 PM
Naclerio NicholasSr VP, Corp DevelopmentOct 15Sale147.852,000295,70923,146Oct 16 08:09 PM
Stapley MarcCFOOct 14Option Exercise36.301,42251,61923,533Oct 16 07:49 PM
Stapley MarcCFOOct 14Sale151.481,422215,40322,111Oct 16 07:49 PM
BRADBURY DANIELDirectorOct 13Option Exercise42.822,10089,92214,566Oct 15 07:59 PM
BRADBURY DANIELDirectorOct 13Sale152.032,100319,25712,466Oct 15 07:59 PM
BOWMAN A BLAINEDirectorOct 07Option Exercise19.614,45687,38217,178Oct 07 07:28 PM
BOWMAN A BLAINEDirectorOct 07Sale159.514,456710,77512,722Oct 07 07:28 PM
BRADBURY DANIELDirectorOct 01Option Exercise42.822,10089,92214,566Oct 02 04:59 PM
Bouchard MichelChief Accounting OfficerOct 01Option Exercise69.3463243,82324,822Oct 02 04:59 PM
Ronaghi MostafaSr VP & CTOOct 01Option Exercise44.3810,000443,80038,604Oct 02 04:58 PM
BRADBURY DANIELDirectorOct 01Sale158.882,100333,64012,466Oct 02 04:59 PM
Bouchard MichelChief Accounting OfficerOct 01Sale158.57632100,21824,190Oct 02 04:59 PM
Ronaghi MostafaSr VP & CTOOct 01Sale159.8110,0001,598,08128,604Oct 02 04:58 PM
BOWMAN A BLAINEDirectorSep 30Option Exercise19.615,00098,05017,722Sep 30 07:59 PM
BOWMAN A BLAINEDirectorSep 30Sale164.025,000820,12312,722Sep 30 07:59 PM
Dadswell CharlesSr VP & General CounselSep 29Sale163.7314724,06842,386Sep 30 07:59 PM
RASTETTER WILLIAM HDirectorSep 29Sale163.7324840,6055,626Sep 30 07:59 PM
FLATLEY JAY TChief Executive OfficerSep 25Option Exercise20.0425,000501,000406,262Sep 26 05:54 PM
FLATLEY JAY TChief Executive OfficerSep 25Sale164.4325,0004,110,804381,262Sep 26 05:54 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 24Option Exercise53.1920,0001,063,80038,630Sep 24 07:38 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 24Sale167.2820,0003,345,62228,630Sep 24 07:38 PM
BOWMAN A BLAINEDirectorSep 23Option Exercise19.615,00098,05017,722Sep 24 07:38 PM
BOWMAN A BLAINEDirectorSep 23Sale168.505,000842,51012,722Sep 24 07:38 PM
BOWMAN A BLAINEDirectorSep 16Option Exercise19.615,00098,05017,722Sep 16 06:28 PM
BOWMAN A BLAINEDirectorSep 16Sale169.605,000847,98012,722Sep 16 06:28 PM
Stapley MarcSr VP & CFOSep 15Option Exercise36.301,42251,61923,533Sep 16 06:28 PM
Naclerio NicholasSr VP, Corp DevelopmentSep 15Option Exercise43.372,00086,74025,146Sep 16 06:28 PM
BRADBURY DANIELDirectorSep 15Option Exercise42.822,10089,92214,566Sep 16 06:28 PM
FLATLEY JAY TChief Executive OfficerSep 15Sale176.495,300935,413381,262Sep 15 08:14 PM
Stapley MarcSr VP & CFOSep 15Sale169.051,422240,38522,111Sep 16 06:28 PM
Naclerio NicholasSr VP, Corp DevelopmentSep 15Sale169.532,000339,05023,146Sep 16 06:28 PM
BRADBURY DANIELDirectorSep 15Sale168.572,100353,99112,466Sep 16 06:28 PM
FLATLEY JAY TChief Executive OfficerSep 11Option Exercise20.0425,000501,000406,262Sep 15 08:14 PM
FLATLEY JAY TChief Executive OfficerSep 11Sale175.9519,7003,466,126386,562Sep 15 08:14 PM
BOWMAN A BLAINEDirectorSep 09Option Exercise19.615,00098,05017,722Sep 10 09:09 PM
BOWMAN A BLAINEDirectorSep 09Sale178.085,000890,37712,722Sep 10 09:09 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 03Option Exercise53.1910,000531,90033,630Sep 04 06:36 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 03Sale180.5910,0001,805,86128,630Sep 04 06:36 PM
Ronaghi MostafaSr VP & CTOSep 02Option Exercise44.3810,000443,80038,604Sep 03 08:11 PM
BOWMAN A BLAINEDirectorSep 02Option Exercise19.615,00098,05017,722Sep 03 08:10 PM
Bouchard MichelVP, Finance & Chief AccountingSep 02Option Exercise69.3463143,75424,876Sep 03 08:10 PM
Ronaghi MostafaSr VP & CTOSep 02Sale179.6610,0001,796,58428,604Sep 03 08:11 PM
BOWMAN A BLAINEDirectorSep 02Sale179.675,000898,35612,722Sep 03 08:10 PM
Bouchard MichelVP, Finance & Chief AccountingSep 02Sale180.07686123,52824,190Sep 03 08:10 PM
FLATLEY JAY TChief Executive OfficerAug 28Option Exercise20.0430,000601,200411,262Aug 29 01:26 PM
FLATLEY JAY TChief Executive OfficerAug 28Sale178.9830,0005,369,344381,262Aug 29 01:26 PM
Dadswell CharlesSr VP & General CounselAug 27Sale180.1215127,19842,454Aug 28 02:24 PM
BOWMAN A BLAINEDirectorAug 26Option Exercise19.615,00098,05017,722Aug 26 08:19 PM
BOWMAN A BLAINEDirectorAug 26Sale179.225,000896,09112,722Aug 26 08:19 PM
BRADBURY DANIELDirectorAug 22Option Exercise36.292,10076,20914,566Aug 25 08:32 PM
BRADBURY DANIELDirectorAug 22Sale172.242,100361,70812,466Aug 25 08:32 PM
BOWMAN A BLAINEDirectorAug 19Option Exercise19.615,00098,05017,722Aug 20 08:16 PM
BOWMAN A BLAINEDirectorAug 19Sale171.705,000858,48312,722Aug 20 08:16 PM
Naclerio NicholasSr VP, Corp DevelopmentAug 15Option Exercise43.372,00086,74025,146Aug 18 07:52 PM
Naclerio NicholasSr VP, Corp DevelopmentAug 15Sale167.232,000334,46123,146Aug 18 07:52 PM
Stapley MarcSr VP & CFOAug 14Option Exercise36.301,42251,61923,533Aug 18 07:52 PM
Stapley MarcSr VP & CFOAug 14Sale166.111,422236,21122,111Aug 18 07:52 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfcrAug 13Option Exercise53.1920,0001,063,80038,630Aug 15 08:20 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfcrAug 13Sale164.6620,0003,293,20128,630Aug 15 08:20 PM
BOWMAN A BLAINEDirectorAug 12Option Exercise14.695,00073,43117,722Aug 14 08:07 PM
BOWMAN A BLAINEDirectorAug 12Sale162.964,700765,91813,022Aug 14 08:07 PM
BOWMAN A BLAINEDirectorAug 05Option Exercise14.095,00070,42517,722Aug 05 08:26 PM
BOWMAN A BLAINEDirectorAug 05Sale159.915,000799,54712,722Aug 05 08:26 PM
Bouchard MichelVP, Finance & Chief AccountingAug 01Option Exercise69.3463143,75424,821Aug 04 07:09 PM
Ronaghi MostafaSr VP & CTOAug 01Option Exercise44.3810,000443,80038,604Aug 04 07:08 PM